<?xml version="1.0" encoding="UTF-8"?>
<p>In the context of this historical opportunity to cure HCV infections, achieve large reductions in disease burden, and even eliminate this blood‐borne virus as a public health concern, the World Health Organization (WHO) formulated the Global Health Sector Strategy on Viral Hepatitis, 2016‐2021 (GHSS)
 <xref rid="hep41310-bib-0022" ref-type="ref">22</xref> and established service coverage targets to eliminate HCV as a public health threat by 2030.
 <xref rid="hep41310-bib-0022" ref-type="ref">22</xref>, 
 <xref rid="hep41310-bib-0023" ref-type="ref">23</xref> The strategy specifically calls for scaling up testing and treatment to achieve by 2030 target coverage levels of 90% for HCV diagnosis, 80% for HCV treatment, as well as 80% reduction in HCV incidence.
 <xref rid="hep41310-bib-0004" ref-type="ref">4</xref>, 
 <xref rid="hep41310-bib-0022" ref-type="ref">22</xref>, 
 <xref rid="hep41310-bib-0023" ref-type="ref">23</xref>
</p>
